Pneumococcal vaccination in times of COVID-19.
作者信息
Vila Córcoles Ángel
机构信息
Direcció d'Atenció Primària Camp de Tarragona, Institut Català de la Salut, Unitat de Suport a la Recerca Tarragona-Reus, Tarragona, Spain.
IDIAP Jordi Gol, Barcelona, Spain.
出版信息
Med Clin (Engl Ed). 2022 Apr 22;158(8):366-368. doi: 10.1016/j.medcle.2022.01.004. Epub 2022 May 5.
Abstract
摘要
相似文献
1
Pneumococcal vaccination in times of COVID-19.新冠疫情期间的肺炎球菌疫苗接种
Med Clin (Engl Ed). 2022 Apr 22;158(8):366-368. doi: 10.1016/j.medcle.2022.01.004. Epub 2022 May 5.
2
The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan.新冠疫情增加了日本对肺炎球菌疫苗接种的需求。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4673-4674. doi: 10.1080/21645515.2021.1958612. Epub 2021 Aug 6.
3
Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic.新冠疫情早期中国60岁及以上老年人接种肺炎球菌疫苗意愿的相关因素
Psychol Health Med. 2022 Jan;27(1):91-105. doi: 10.1080/13548506.2021.1905862. Epub 2021 Mar 26.
4
Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations.Covid-19 大流行：一个提高高危人群意识和疫苗接种率的机会。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3472-3473. doi: 10.1080/21645515.2021.1926760. Epub 2021 Jun 7.
5
Patients' Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections.新冠疫情期间患者对流感和肺炎球菌疫苗接种的认知与了解：针对感染风险患者的在线调查
Vaccines (Basel). 2021 Nov 22;9(11):1372. doi: 10.3390/vaccines9111372.
6
Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.3010 例新冠病毒肺炎患者在弗留利-威尼斯朱利亚大区（意大利北部）的临床、人口统计学特征和住院情况。一项多变量、基于人群、统计学分析。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):226-234. doi: 10.19191/EP20.5-6.S2.122.
7
[Impact of co-infection of streptococcus pneumoniae and pneumococcal vaccination on the clinical outcomes of coronavirus disease 19].[肺炎链球菌合并感染及肺炎球菌疫苗接种对新型冠状病毒肺炎临床结局的影响]
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 May 6;56(5):659-667. doi: 10.3760/cma.j.cn112150-20211119-01072.
8
Attitudes towards influenza and pneumococcal vaccines in parents of asthmatic children during the COVID-19 pandemic.新冠疫情期间哮喘儿童家长对流感疫苗和肺炎球菌疫苗的态度
Pediatr Pulmonol. 2022 Apr;57(4):871-877. doi: 10.1002/ppul.25818. Epub 2022 Jan 17.
9
Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?年龄和 COVID-19 病理学严重程度的位置：乳铁蛋白和肺炎球菌疫苗接种能否解释低婴儿死亡率和地区差异？
Bioessays. 2020 Nov;42(11):e2000076. doi: 10.1002/bies.202000076. Epub 2020 Aug 31.
10
Leveraging Interdisciplinary Teams for Pre-Visit Planning to Improve Pneumococcal Immunization Rates Among Internal Medicine Subspecialty Practices.利用跨学科团队进行预访规划，提高内科亚专科实践中肺炎球菌免疫接种率。
J Prim Care Community Health. 2021 Jan-Dec;12:21501319211060986. doi: 10.1177/21501319211060986.
引用本文的文献
1
Coinfection with SARS-CoV-2 among patients with Streptococcus pneumoniae in Casablanca.卡萨布兰卡肺炎链球菌患者中合并感染新冠病毒的情况。
BMC Infect Dis. 2025 May 26;25(1):755. doi: 10.1186/s12879-025-10953-z.
2
Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature.近期欧洲成人国家免疫计划中肺炎球菌疫苗接种的变化及其对覆盖率的影响：对已发表和灰色文献的系统评价。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2279394. doi: 10.1080/21645515.2023.2279394. Epub 2023 Nov 28.
3
A Profile of Adult Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Patients According to Pneumococcal Vaccination Status.根据肺炎球菌疫苗接种状况分析成人新型冠状病毒肺炎患者概况
Vaccines (Basel). 2023 Oct 24;11(11):1630. doi: 10.3390/vaccines11111630.
本文引用的文献
1
Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.保护易感染肺炎球菌和流感的成年人免受 SARS-CoV-2 感染。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-7. doi: 10.1080/21645515.2021.1957647. Epub 2021 Aug 18.
2
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.新型冠状病毒病（COVID-19）大流行对侵袭性肺炎球菌病的影响以及与严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）发生肺炎球菌合并感染的风险：英格兰全国前瞻性队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728.
3
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.60 至 64 岁成人中 20 价肺炎球菌结合疫苗（PCV20）的安全性、耐受性和免疫原性。
Clin Infect Dis. 2021 Oct 5;73(7):e1489-e1497. doi: 10.1093/cid/ciaa1045.
4
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
5
Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016.13 价和 23 价肺炎球菌疫苗在中老年人群中的临床效果：EPIVAC 队列研究，2015-2016 年。
Vaccine. 2020 Jan 29;38(5):1170-1180. doi: 10.1016/j.vaccine.2019.11.012. Epub 2019 Nov 20.
6
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.《免疫实践咨询委员会关于 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗在年龄≥65 岁成人中使用的更新建议》。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5.
7
Cost Effectiveness of Elderly Pneumococcal Vaccination in Presence of Higher-Valent Pneumococcal Conjugate Childhood Vaccination: Systematic Literature Review with Focus on Methods and Assumptions.老年肺炎球菌疫苗接种在高价肺炎球菌结合儿童疫苗接种存在时的成本效益：系统文献综述，重点关注方法和假设。
Pharmacoeconomics. 2019 Sep;37(9):1093-1127. doi: 10.1007/s40273-019-00805-5.
8
Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe.成人肺炎球菌病疫苗接种：欧洲国家指南比较。
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):785-791. doi: 10.1007/s10096-019-03485-3. Epub 2019 Feb 18.
9
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.13 价肺炎球菌结合疫苗对美国老年社区获得性肺炎住院治疗的有效性：一项基于检验的研究设计。
Clin Infect Dis. 2018 Oct 30;67(10):1498-1506. doi: 10.1093/cid/ciy312.
10
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.欧洲成年人社区获得性肺炎的负担：文献综述。
Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19.
Zotero 插件